Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-05-12

Clinical Trial Update: Relationship Between Neurotransmitter Receptor Polymorphisms, Plasma Concentrations and Clinical Response to Clozapine

View source ↗

Summary

This completed trial examined how neurotransmitter receptor polymorphisms and Clozapine plasma levels relate to clinical response in schizophrenia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Clozapine (Clozapine)

Snippet

Sponsor: Delwyn D. Miller | Conditions: Schizophrenia | Status: COMPLETED